Abbott Labs (GB:0Q15)
LSE:0Q15

Abbott Labs (0Q15) Income Statement

0 Followers

Abbott Labs Income Statement

Last quarter (Q1 2023), Abbott Labs's total revenue was $9.75B, a decrease of -18.06% from the same quarter last year. In Q1, Abbott Labs's net income was $1.32B. See Abbott Labs’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 41.51B$ 43.65B$ 43.08B$ 34.61B$ 31.90B$ 30.58B
Cost of Revenue
$ 18.49B$ 19.14B$ 18.54B$ 15.00B$ 13.23B$ 12.71B
Gross Profit
$ 23.02B$ 24.51B$ 24.54B$ 19.61B$ 18.67B$ 17.87B
Operating Expense
$ 16.06B$ 16.15B$ 16.11B$ 14.25B$ 14.14B$ 14.22B
Operating Income
$ 6.96B$ 8.36B$ 8.43B$ 5.36B$ 4.53B$ 3.65B
Net Non Operating Interest Income Expense
$ -310.00M$ -375.00M$ -490.00M$ -500.00M$ -576.00M$ -721.00M
Other Income Expense
$ 127.00M$ -321.00M$ 276.00M$ 111.00M$ 121.00M$ -56.00M
Pretax Income
$ 6.99B$ 8.31B$ 8.21B$ 4.97B$ 4.08B$ 2.87B
Tax Provision
$ 1.19B$ 1.37B$ 1.14B$ 497.00M$ 390.00M$ 539.00M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ 5.80B$ 6.93B$ 7.07B$ 4.50B$ 3.69B$ 2.37B
Basic EPS
$ 2.89-$ 3.97$ 2.52$ 2.07$ 1.34
Diluted EPS
$ 2.54-$ 3.94$ 2.50$ 2.06$ 1.33
Basic Average Shares
$ 4.74B-$ 1.77B$ 1.77B$ 1.77B$ 1.76B
Diluted Average Shares
$ 5.28B-$ 1.79B$ 1.79B$ 1.78B$ 1.77B
Dividend Per Share
$ 1.41-$ 1.80$ 1.44$ 1.28$ 1.12
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
$ 2.58-$ 5.21$ 3.65$ 3.24$ 2.88
Rent Expense Supplemental
------
Total Expenses
$ 34.55B$ 35.29B$ 34.65B$ 29.25B$ 27.37B$ 26.93B
Net Income From Continuing And Discontinued Operation
$ 5.80B$ 6.93B$ 7.07B$ 4.50B$ 3.69B$ 2.37B
Normalized Income
$ 4.49B-$ 7.07B$ 4.46B$ 3.75B$ 2.49B
Interest Expense
$ 427.00M-$ 533.00M$ 546.00M$ 670.00M$ 826.00M
EBIT
$ 7.47B$ 8.68B$ 8.74B$ 5.51B$ 4.75B$ 3.70B
EBITDA
$ 10.41B$ 10.69B$ 12.28B$ 8.84B$ 7.76B$ 6.98B
Currency in USD

Abbott Labs Earnings and Revenue History


What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis